| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $73.1M | +13.4% |
| Cost of Revenue | $33.5M | +4.4% |
| Gross Profit | $32.6M | +11.2% |
| R&D Expense | $1.3M | -9.0% |
| SG&A Expense | $27.8M | +14.0% |
| Operating Income | $3.5M | +0.2% |
| Pre-tax Income | $6.0M | +87.6% |
| Income Tax | $1.5M | +28.9% |
| Net Income | $2.9M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.4M | -9.2% |
| Accounts Receivable | $7.5M | -42.3% |
| Current Assets | $46.3M | -2.4% |
| Total Assets | $62.4M | -2.7% |
| Current Liabilities | $19.7M | -17.4% |
| Long-term Debt | $77K | +34.8% |
| Total Liabilities | $20.2M | -18.1% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $447K | -84.6% |
| Capital Expenditures | $1.4M | +168.3% |
| Investing Cash Flow | -$1.3M | -337.3% |
| Financing Cash Flow | $823K | +243.5% |
| Free Cash Flow | -$936K | -139.1% |
| +327.5% |
| EPS (Basic) | $0.25 | +316.7% |
| EPS (Diluted) | $0.25 | +316.7% |
| Stockholders' Equity |
| $37.8M |
| +8.6% |